<DOC>
	<DOCNO>NCT03007914</DOCNO>
	<brief_summary>The aim study compare effectiveness treatment two cohort COPD patient : one , traditional Chinese medicine ( TCM ) cohort , evaluate certain effect ; , conventional medicine treatment cohort , base 2015 Global Initiative Chronic Obstructive Lung Disease ( GOLD ) .</brief_summary>
	<brief_title>Effect Traditional Chinese Medicine Outcomes COPD Patients</brief_title>
	<detailed_description>COPD , high prevalence , morbidity , mortality economic burden , affect million worldwide . Although many therapy exist develop relieve symptom reduce mortality COPD , study placebo-controlled efficacy study highly select population . There clinical trial compare therapeutic alternative real world . Furthermore , randomize control trial comprehensive TCM intervention , especially base TCM pattern , certain evidence show definite effect COPD patient . In addition , study real world population COPD receive different therapy efficacy evidence find wide variation care delivery . In short , need cohort study COPD . This multi-center , prospective , cohort study evaluate effectiveness TCM COPD patient . The cohort study enroll approximately 2540 patient two cohort , one , TCM cohort , evaluate certain effect ; , conventional medicine treatment cohort , base 2015 Global Initiative Chronic Obstructive Lung Disease ( GOLD ) .Subjects two cohort followed-up 2 years.The primary outcome measure frequency exacerbation . The secondary efficacy measure include mortality rate all-cause mortality , FEV1 , dyspnea ( MMRC ) , exercise capacity ( 6MWD ) , quality life ( CAT , SF-36 COPD-PRO ) , effectiveness satisfaction treatment ( ESQ-COPD ) .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>A confirmed diagnosis COPD . Medically stable . Age 40 80 year . Syndrome differentiation belong syndrome deficiency deficiency lung qi , deficiency pulmonicsplenic qi , syndrome insufficiency qi lung kidney , syndrome insufficiency qi yin lung kidney . With informed consent sign . Capable comply dose regimen visit schedule . Pregnant breastfeed woman . Any psychiatric condition render patient unable understand nature , scope possible consequence study . Malignancy patient undergone resection , radiation therapy chemotherapy within last 5 year . Current respiratory disorder COPD ( e.g. , bronchiectasis , bronchial asthma , tuberculosis , lung fibrosis , pulmonary thromboembolic , diffuse panbronchiolitis ) . Complicated heart failure ( NYHA Class III IV ) , myocardial infarction within six month , unstable hemodynamics . Complicated serious hepatic renal disease ( liver cirrhosis , portal hypertension , bleed varicose vein , dialysis , renal transplantation ) . Complicated congenital acquire immune deficiency . Participating trial allergic use medicine .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Pulmonary Disease , Chronic Obstructive</keyword>
	<keyword>Medicine , Chinese Traditional</keyword>
	<keyword>Humans</keyword>
	<keyword>Treatment Outcome</keyword>
</DOC>